03075nam a22003975i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001400153072001600167072002300183072001500206245019500221250001800416264007200434300006600506336002600572337002600598338003600624347002400660505080700684520076501491650002202256650002202278700008802300700007502388710003402463773002602497776003602523776003602559776003602595856004602631978-981-97-9519-2DE-He21320251030114913.0cr nn 008mamaa241231s2024    si |    s    |||| 0|eng d  a97898197951927 a10.1007/978-981-97-9519-22doi 4aRC799-869 7aMNG2bicssc 7aMED0310002bisacsh 7aMNG2thema10aMetabolic Dysfunction-Associated Steatotic Liver Diseaseh[electronic resource] :bPrevalence, research insights and the future directions /cedited by Nahum Méndez-Sánchez, Xingshun Qi.  a1st ed. 2024. 1aSingapore :bSpringer Nature Singapore :bImprint: Springer,c2024.  aVIII, 170 p. 26 illus., 25 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 a -- Chapter 1 Introduction of MAFLD/MASLD.  -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC.  -- Chapter 3 Decoding MAFLD’s pathophysiology.  -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage.  -- Chapter 5 Diagnostic Advances in MAFLD/MASLD.  -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes.  -- Chapter 7 MAFLD as a multisystemic disease.  -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship.  -- Chapter 9 Current Standards in Therapeutic Management.  -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS.  -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management.  -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS.  -- Chapter 13 Looking ahead.  -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.  aThis book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition. 0aGastroenterology.14aGastroenterology.1 aMéndez-Sánchez, Nahum.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aQi, Xingshun.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978981979518508iPrinted edition:z978981979520808iPrinted edition:z978981979521540uhttps://doi.org/10.1007/978-981-97-9519-2